|
⚲
|
| Keyboard |
| Abingworth Management Inc
✚
|
|
|---|---|
| CRD # | 157466 |
| SEC # | 801-73401 |
| CIK # | 0001291892, 0001397144 |
| AUM | |
| Employees | 24 (58% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 650-926-0600 |
| Address | 3000 Sand Hill Road Menlo Park, CA 94025 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Medline Inc | 8.3 | ||
| Standardaero Inc | 2.2 | ||
| Phathom Pharmaceuticals Inc | 0.0 | ||
| PONY AI Inc | 0.0 | ||
| Invitation Homes Inc | 0.0 | ||
| U-Store-It Trust | 0.0 | ||
| Homology Medicines Inc | 0.0 | ||
| Getty Images Holdings Inc | 0.0 | ||
| Spruce Biosciences Inc | 0.0 | ||
| Forward Air Corp | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Abingworth Bioequities Master Fund Limited | 2012-03-30 | 80.8 M | |
| VC | Abingworth BioVentures IIIA LP | 2012-03-30 | 16.4 M | |
| VC | Abingworth BioVentures IIIB LP | 2012-03-30 | 10.0 M | |
| VC | Abingworth BioVentures IIIC LP | 2012-03-30 | 6.0 M | |
| VC | Abingworth BioVentures III Executives LP | 2012-03-30 | 0.3 M | |
| VC | Abingworth BioVentures II SICAV in Voluntary Liquidation | 2012-03-30 | 2.8 M | |
| VC | Abingworth BioVentures IV Executives LP | 2012-03-30 | 0.5 M | |
| VC | Abingworth BioVentures IV LP | 2012-03-30 | 57.1 M |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 9 | 1,731.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 9 | 1,731.9 |
| By Discretionary | ||
| Discretionary | 9 | 1,731.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 9 | 1,731.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 1,731.9 | |
| United States Persons | 0.0 | |
| Total | 9 | 1,731.9 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001291892] | |
| 4 | [0001291892] | |
| SC 13D | [0001291892] | |
| 13F-HR | [0001397144] | |
| 13F-NT | [0001397144] | |
| 3 | [0001397144] | |
| 4 | [0001397144] | |
| SC 13D | [0001397144] | |
| SC 13G | [0001397144] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Jasper Therapeutics Inc JSPR
Voting Common Stock
|
2024-02-08 | Buy | 190,000 | $12.95 | 2,460,500 |
|
Soleno Therapeutics Inc SLNO
Common Stock
|
2023-09-28 | Conversion | 329,930 | $1.75 | 577,378 |
|
Soleno Therapeutics Inc SLNO
Tranche A Warrants · derivative
|
2023-09-28 | Conversion | 1,092,056 | $0.00 | |
|
Soleno Therapeutics Inc SLNO
Prefunded Warrants · derivative
|
2023-09-28 | Conversion | 762,126 | $1.75 | 1,333,720 |
|
Soleno Therapeutics Inc SLNO
Tranche A Warrants · derivative
|
2023-05-08 | Buy | 1,092,056 | $0.44 | 480,505 |
|
Soleno Therapeutics Inc SLNO
Tranche B Warrants · derivative
|
2023-05-08 | Buy | 1,778,000 | $0.44 | 782,320 |
|
Jasper Therapeutics Inc JSPR
Voting Common Stock
|
2023-01-27 | Buy | 3,133,333 | $1.50 | 4,700,000 |
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2022-08-17 | Option exercise | 9,925 | $11.00 | 109,175 |
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2022-08-17 | Sell | 3,281 | $19.88 | 65,226 |
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2022-08-17 | Sell | 6,472 | $20.42 | 132,158 |
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2022-08-17 | Sell | 172 | $21.07 | 3,624 |
|
Vera Therapeutics Inc VERA
Stock Option (right to buy) · derivative
|
2022-08-17 | Option exercise | 9,925 | $0.00 | |
|
Soleno Therapeutics Inc SLNO
Common Stock
|
2022-03-29 | Buy | 7,720,000 | ||
|
Soleno Therapeutics Inc SLNO
Warrant (right to buy) · derivative
|
2022-03-29 | Buy | 7,720,000 | ||
|
Jasper Therapeutics Inc JSPR
Stock Option (right to buy) · derivative
|
2022-03-21 | Grant | 78,045 | $0.00 | |
|
Sierra Oncology Inc SRRA
Common Stock, $0.001 par value
|
2022-01-31 | Buy | 150,000 | $27.00 | 4,050,000 |
|
Sierra Oncology Inc SRRA
Series B Warrants (right to buy) · derivative
|
2022-01-28 | Option exercise | 287,471 | $0.00 | |
|
Sierra Oncology Inc SRRA
Common Stock, $0.001 par value
|
2022-01-28 | Option exercise | 287,471 | $13.20 | 3,794,617 |
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (right to buy) · derivative
|
2021-10-06 | Grant | 40,000 | $0.00 | |
|
Soleno Therapeutics Inc SLNO
Stock Option (right to buy) · derivative
|
2021-06-01 | Grant | 31,862 | $0.00 | |
| showing 20 of 69 most recent transactions | |||||